tiprankstipranks
Trending News
More News >

D.Western Therapeutics Partners with Mie University for Drug Development

Story Highlights
D.Western Therapeutics Partners with Mie University for Drug Development

Don’t Miss TipRanks’ Half-Year Sale

The latest announcement is out from D.Western Therapeutics Institute ( (JP:4576) ).

D.Western Therapeutics Institute, Inc. has entered a joint research agreement with Mie University to develop new drugs for lifestyle-related diseases using their low-molecular-weight compounds. This collaboration will leverage zebrafish models for efficient drug screening, potentially enhancing the company’s capabilities and impact in the pharmaceutical industry, though it will not affect the current fiscal year’s earnings forecast.

More about D.Western Therapeutics Institute

D.Western Therapeutics Institute, Inc. operates in the pharmaceutical industry, focusing on the development of kinase inhibitors with a strong track record in ophthalmology.

YTD Price Performance: -50.45%

Technical Sentiment Signal: Strong Buy

Current Market Cap: €30.13M

See more data about 4576 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1